Katherine Moxley - Concepedia

Author

Katherine Moxley

University of Oklahoma Health Sciences Center ORCID

Also Known As

Carlos Gilberto Carlotti, Edna M. Mora Pinero, Federico Valdivieso, Jenette Creaney, Joan Walker, Jose Sebastião Dos Santos, K M Moxley, K Moxley, K. Moxley, K.M. Moxley

169

Publications

37.8K

Citations

H-Index

Concepts

All Affiliations

University of Oklahoma Health Sciences Center Memorial Sloan Kettering Cancer Center NRG Oncology University of Oklahoma Roswell Park Comprehensive Cancer Center

About

Katherine Moxley is an author at University of Oklahoma Health Sciences Center specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	2.2K
2	Cell Biology	5	5	174
3	Engineering	3	3	1K
4	Health Sciences	2	2	76
5	Immunology	1	1	12

Katherine Moxley

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer Daniela Matei, Virginia L. Filiaci, Marcus E. Randall, New England Journal of Medicine	2019	444
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy Nicolas Wentzensen, Joan L. Walker, Michael A. Gold, Journal of Clinical Oncology	2014	214
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, The Lancet OncologyCervical CancerMetronomic TherapyPathologyRecurrent Cervical Cancer	2023	175
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study Bradley J. Monk, James Kauderer, Katherine Moxley, Gynecologic Oncology Phase Ii EvaluationMedicineCancer ManagementGynecologyWeekly Paclitaxel	2018	110
LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response Ji Hee Ha, Rangasudhagar Radhakrishnan, Muralidharan Jayaraman, Cancer Research	2018	105
A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients Akhil Srivastava, Katherine Moxley, R. Ruskin, The AAPS Journal OncologyExosomesCancer DetectionMedicineGynecology	2018	101
Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts Rangasudhagar Radhakrishnan, Ji Hee Ha, Muralidharan Jayaraman, Cancer Letters MedicineCancer-associated Fibroblast-phenotypeAutophagyPathologyFibroblast Growth Factor	2018	99

Page 1